Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, October 28 at 2:00 PM ET

Register Free →

CENTENE CORPORATION

Parent6 subsidiariesUEI: NANFEH9AAH43CAGE: 6MPQ9

CENTENE CORPORATION is a federal contractor, registered under UEI NANFEH9AAH43 and CAGE code 6MPQ9. It has been awarded $839,782,800 in federal contracts. Primary work spans Unknown NAICS. Top awarding agencies include Department Of Health And Human Services (hhs).

Contact Information

Registration and classification details

Registration

UEI Code

NANFEH9AAH43

CAGE Code

6MPQ9

Entity Structure

Corporate Entity (Not Tax Exempt)

Established

N/A

Business Classifications

For Profit Organization

NAICS Codes

524114Direct Health and Medical Insurance Carriers(Primary)

Federal Contracting Overview

Award totals, agency breakdown, NAICS distribution, and geographic footprint.

AI Capability Profile

CENTENE CORPORATION specializes in managed care and health plan administration services, delivering end-to-end solutions for government-sponsored health programs. Their core capabilities include member enrollment and eligibility management, claims processing, provider network coordination, utilizati...

CENTENE CORPORATION specializes in managed care and health plan administration services, delivering end-to-end solutions for government-sponsored health programs. Their core capabilities include member enrollment and eligibility management, claims processing, provider network coordination, utilization review, and population health analytics. The company leverages integrated IT platforms to support risk-based care models, including Medicaid, Medicare Advantage, and dual-eligible programs, with deep expertise in compliance with federal and state regulatory frameworks such as CMS guidelines and HIPAA. Technical strengths include data interoperability, real-time claims adjudication systems, member portals, and predictive modeling for care coordination. Their differentiators lie in scalable infrastructure for high-volume enrollment environments and robust quality measurement reporting systems aligned with HEDIS and Star Ratings. Award history is not available to confirm specific agency relationships, so no definitive patterns of engagement with federal or state entities can be inferred from the provided data. The primary NAICS code 524114 corresponds to Health and Medical Insurance Carriers, indicating that CENTENE operates as a health plan sponsor and administrator, not a traditional IT services contractor. In practice, this means they manage financial risk, coordinate clinical services, and ensure regulatory compliance across public health programs, positioning them as a key player in the public-sector managed care market. CENTENE is structured as a large, multi-state enterprise (2L entity) headquartered in Saint Louis, Missouri. The company holds no government-recognized certifications such as 8(a), HUBZone, or WOSB. Its geographic footprint spans multiple states through state-specific subsidiaries, enabling it to deliver localized health plan services under federal-state partnership models. The organization’s market positioning is centered on operational scale and regulatory expertise in public health insurance administration.

Key Performance Metrics

Awards Count

162

All time

Active

0

Currently performing

Completed

162

Past period of performance

Total Awards

All time

Award Analytics & Distribution

Awards by Agency
Awards by NAICS
- Unknown NAICS$839.8M100%
Awards by Agency Over Time
Awards by Place of Performance

Compete with CENTENE CORPORATION

Track the contractors you bid against, and the work they win

Award history, agency mix, and NAICS coverage for CENTENE CORPORATION

AI-powered matching against your own capabilities and past performance

Teaming and subcontracting signals on every award

Automated alerts when a competitor wins in your market

Miguel
Hillary
Keith Deutsch
Christine

Join 750+ contractors already using CLEATUS

Open opportunities in CENTENE CORPORATION's top NAICS codes and agencies

NAICS: 541715
SBIR / STTR
NIH Small Business Technology Transfer Grant (Parent STTR [R41/R42] Clinical Trial Optional)
Solicitation # PA-27-102
The NIH Small Business Technology Transfer (STTR) grant, solicitation PA-27-102, provides early-stage funding for U.S. small business concerns (SBCs) to conduct research and development of commercial products in formal collaboration with non-profit research institutions. The program is designed to enhance health and reduce illness through a phased approach: Phase I focuses on establishing technical merit and feasibility, while Phase II advances the research toward commercialization. Eligible applicants must be for-profit entities located in the U.S., owned more than 50 percent by U.S. citizens or permanent residents, and employ no more than 500 people. The program accepts Phase I, Phase II, Direct to Phase II, and Fast-Track applications, with the latter two being NIH-specific options to accelerate development. Funding limits vary by the awarding NIH Institute or Center, with Phase I budgets typically ranging from 400,000 to 700,000 dollars and Phase II budgets reaching up to 3,000,000 dollars. Applications are evaluated via a peer review system based on an overall impact score, considering commercial potential, technical feasibility, and the quality of the commercialization plan. While clinical trials are generally optional, they require a specific regulatory plan and adherence to strict safety and registration guidelines; notably, several institutes, including NIAID and NIAMS, do not accept clinical trials under this NOFO. Applicants must maintain active registrations in SAM, possess a Unique Entity Identifier, and comply with cybersecurity incident reporting requirements, including notifying HHS within 48 hours of a discovery.
Department of Health and Human Services

POSTED

5 months ago

DEADLINE

in 6 months
View Details
NAICS: 541715
SBIR / STTR
NIH, CDC and FDA Small Business Innovation Research Grant (Parent SBIR [R43/R44] Clinical Trial Optional)
Solicitation # PA-27-100
The NIH, CDC, and FDA Small Business Innovation Research (SBIR) Grant, solicitation PA-27-100, provides early-stage funding to United States small business concerns (SBCs) to conduct research and development for commercial products. The program is structured in phases, with Phase I focusing on establishing technical merit and feasibility, and Phase II advancing the project toward commercialization. Eligible applicants include for-profit U.S. businesses with no more than 500 employees. The funding opportunity accepts Phase I, Phase II, Direct to Phase II, and Fast-Track applications, with the latter two being specific to the NIH. Budget limits vary by participating institute, with Phase I awards typically ranging from 400,000 to 700,000 dollars and Phase II awards reaching up to 3,000,000 dollars. Applications are evaluated through a peer review system based on scientific and technical merit, significance, and the suitability of the environment for success. While clinical trials are generally optional, they are prohibited for specific components, including all FDA centers and several NIH institutes such as NIAMS and NIDCR. Recipients must adhere to strict compliance requirements, including maintaining active SAM registration, disclosing foreign relationships, and implementing cybersecurity incident reporting procedures that notify agencies within 48 hours of discovery. All applications must be submitted electronically, with a final expiration date of April 06, 2027.
Department of Health and Human Services

POSTED

5 months ago

DEADLINE

in 6 months
View Details
NAICS: 541715
SBIR / STTR
SBIR/STTR Commercialization Readiness Pilot (CRP) Program (Parent SB1 Clinical Trial Optional)
Solicitation # PAR-27-098
The SBIR/STTR Commercialization Readiness Pilot (CRP) Program, solicitation PAR-27-098, is a funding opportunity provided by the National Institutes of Health (NIH) to help U.S.-based small business concerns transition technology from late-stage research and development to full commercialization. This program is specifically available to recipients of prior or active NIH SBIR or STTR Phase II or Phase IIB Strategic Breakthrough awards. The CRP supports activities that bridge the gap to market, including technical assistance for regulatory and intellectual property strategies, manufacturing scale-up, independent replication of key studies, and clinical trials. While significant outsourcing to contract research organizations is permitted, the small business must maintain a substantial role in project oversight and management. Eligible applicants must be for-profit organizations with no more than 500 employees and maintain active registrations in the System for Award Management and the SBA Company Registry. Project periods are limited to a maximum of three years, with budget ceilings varying by participating Institute or Center, ranging from 500,000 dollars to 2 million dollars, or following SBA guidelines for certain institutes. Applications are evaluated via NIH peer review based on scientific and technical merit, commercial potential, and relevance to program priorities. Key submission requirements include a detailed regulatory plan and a CRP progress report, while costs for patent or FDA filing fees and separate Technical and Business Assistance funding are strictly prohibited.
Department of Health and Human Services

POSTED

5 months ago

DEADLINE

in 6 months
View Details